A phase I study of Gleevec (imatinib mesylate) administered concomitantly with cytosine arabinoside (ara-c) in patients with Philadelphia positive chronic myeloid leukemia (CML)

• DRUKER BJ

収録刊行物

• Blood

  Blood 98 839-, 2001

詳細情報

• CRID: 1571417125024192512
• NII論文ID: 10013148842
• NII書誌ID: AA00567156
• データソース種別:
  • CiNii Articles